Patents by Inventor Yinglin Han

Yinglin Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240017112
    Abstract: The present disclosure may provide a balance beam. The balance beam may include a beam body and one or more support assemblies configured to support the beam body. The beam body may include one or more chambers. Each of the one or more chambers may be configured to accommodate at least a portion of one of the one or more support assemblies. Each of the one or more support assemblies may be connected with the beam body via a first connection. The support assembly may be configured to rotate, through the first connection, along a first rotation axis for moving into the one or more chambers.
    Type: Application
    Filed: April 10, 2023
    Publication date: January 18, 2024
    Inventor: Yinglin HAN
  • Publication number: 20160168188
    Abstract: The present invention relates to the synthesis of ent-progesterone and intermediates thereof.
    Type: Application
    Filed: September 15, 2015
    Publication date: June 16, 2016
    Inventors: John W. Cran, Yinglin Han, Faliang Zhang
  • Publication number: 20160016988
    Abstract: The present invention relates to the synthesis of ent-progesterone and intermediates thereof.
    Type: Application
    Filed: March 15, 2014
    Publication date: January 21, 2016
    Inventors: John W. CRAN, Yinglin HAN, Faliang ZHANG
  • Publication number: 20140275572
    Abstract: The present invention relates to the synthesis of ent-progesterone and intermediates thereof.
    Type: Application
    Filed: March 15, 2014
    Publication date: September 18, 2014
    Inventors: John W. Cran, Yinglin Han, Faliang Zhang
  • Patent number: 7842813
    Abstract: The present invention relates generally to novel methods for the synthesis of O-[5-(4-amino-thiazol-2-yl)-pyridin-2-ylmethyl]-hydroxylamine which is an essential reagent in the synthesis of one of the bridged erythromycin derivatives and their respective pharmaceutically acceptable salts in PCT Application WO 03/097659 A1.
    Type: Grant
    Filed: May 8, 2009
    Date of Patent: November 30, 2010
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Datong Tang, Yinglin Han, Yanhe Huang, Ly Tam Phan, Yat Sun Or, Zhe Wang
  • Publication number: 20090281324
    Abstract: The present invention relates generally to novel methods for the synthesis of O-[5-(4-amino-thiazol-2-yl)-pyridin-2-ylmethyl]-hydroxylamine which is an essential reagent in the synthesis of one of the bridged erythromycin derivatives and their respective pharmaceutically acceptable salts in PCT Application WO 03/097659 A1.
    Type: Application
    Filed: May 8, 2009
    Publication date: November 12, 2009
    Inventors: Datong Tang, Yinglin Han, Yanhe Huang, Ly Tam Phan, Yat Sun Or, Zhe Wang